Arthrex, Inc. v. Smith & Nephew, Inc.

Decision Date31 October 2019
Docket Number2018-2140
Parties ARTHREX, INC., Appellant v. SMITH & NEPHEW, INC., Arthrocare Corp., Appellees United States, Intervenor
CourtU.S. Court of Appeals — Federal Circuit

Anthony P. Cho, Carlson, Gaskey & Olds, PC, Birmingham, MI, argued for appellant. Also represented by David Louis Atallah, David J. Gaskey, Jessica E. Zilberberg.

Charles T. Steenburg, Wolf, Greenfield & Sacks, PC, Boston, MA, argued for appellees. Also represented by Richard Giunta, Turhan Sarwar ; Michael N. Rader, New York, NY.

Melissa N. Patterson, Appellate Staff, Civil Division, United States Department of Justice, Washington, DC, argued for intervenor. Also represented by Courtney Dixon, Scott R. Mcintosh, Joseph H. Hunt; Sarah E. Craven, Thomas W. Krause, Joseph Matal, Farheena Yasmeen Rasheed, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA.

Before Moore, Reyna, and Chen, Circuit Judges.

Moore, Circuit Judge.

Arthrex, Inc. appeals from the final written decision of the Patent Trial and Appeal Board holding claims 1, 4, 8, 10–12, 16, 18, and 25–28 of U.S. Patent No. 9,179,907 unpatentable as anticipated. Arthrex appeals this decision and contends that the appointment of the Board’s Administrative Patent Judges ("APJs") by the Secretary of Commerce, as currently set forth in Title 35, violates the Appointments Clause, U.S. Const., art. II, § 2, cl. 2. We agree and conclude that the statute as currently constructed makes the APJs principal officers. To remedy the violation, we follow the approach set forth by the Supreme Court in Free Enterprise Fund v. Public Company Accounting Oversight Board , 561 U.S. 477, 130 S.Ct. 3138, 177 L.Ed.2d 706 (2010) and followed by the D.C. Circuit in Intercollegiate Broadcasting System, Inc. v. Copyright Royalty Board , 684 F.3d 1332 (2012). As the Supreme Court instructs, " [g]enerally speaking, when confronting a constitutional flaw in a statute, we try to limit the solution to the problem,’ severing any ‘problematic portions while leaving the remainder intact.’ " Free Enterprise Fund , 561 U.S. at 508, 130 S.Ct. 3138 (quoting Ayotte v. Planned Parenthood of Northern New Eng. , 546 U.S. 320, 328–29, 126 S.Ct. 961, 163 L.Ed.2d 812 (2006) ). We conclude that severing the portion of the Patent Act restricting removal of the APJs is sufficient to render the APJs inferior officers and remedy the constitutional appointment problem. As the final written decision on appeal issued while there was an Appointments Clause violation, we vacate and remand. Following Lucia v. S.E.C. , ––– U.S. ––––, 138 S. Ct. 2044, 201 L.Ed.2d 464 (2018), the appropriate course of action is for this case to be remanded to a new panel of APJs to which Arthrex is entitled.

BACKGROUND

Arthrex owns the ’907 patent, which is directed to a knotless suture securing assembly. Smith & Nephew, Inc. and Arthrocare Corp. (collectively "Petitioners" or "Appellees") filed a petition requesting inter partes review of claims 1, 4, 8, 10–12, 16, 18, and 25–28 of the ’907 patent.

Inter partes review is a " ‘hybrid proceeding’ with ‘adjudicatory characteristics’ similar to court proceedings."

Saint Regis Mohawk Tribe v. Mylan Pharms. , 896 F.3d 1322, 1326 (Fed. Cir. 2018). After a petitioner files a petition requesting that the Board consider the patentability of issued patent claims, the Director of the United States Patent and Trademark Office ("USPTO") determines whether to institute an inter partes review proceeding. 35 U.S.C. § 314.1 A three-judge panel of Board members then conducts the instituted inter partes review. Id. § 316(c).2 If an instituted review is not dismissed before the conclusion of the proceedings, the Board issues a final written decision determining the patentability of challenged claims. Id. § 318(a). Once the time for appeal of the decision expires or any appeal has been terminated, the Director issues and publishes a certificate canceling any claim of the patent finally determined to be unpatentable. Id. § 318(b).

The inter partes review of the ’907 patent was heard by a three-judge panel consisting of three APJs. The Board instituted review and after briefing and trial, the Board issued a final written decision finding the claims unpatentable as anticipated. J.A. 12, 14, 42.

ANALYSIS
A. Waiver

Appellees and the government argue that Arthrex forfeited its Appointments Clause challenge by not raising the issue before the Board. Although "[i]t is the general rule ... that a federal appellate court does not consider an issue not passed upon below," we have discretion to decide when to deviate from that general rule. Singleton v. Wulff , 428 U.S. 106, 120–21, 96 S.Ct. 2868, 49 L.Ed.2d 826 (1976). The Supreme Court has included Appointments Clause objections to officers as a challenge which could be considered on appeal even if not raised below. Freytag v. Commissioner of Internal Revenue , 501 U.S. 868, 878–79, 111 S.Ct. 2631, 115 L.Ed.2d 764 (1991) ; Glidden Co. v. Zdanok , 370 U.S. 530, 535–36, 82 S.Ct. 1459, 8 L.Ed.2d 671 (1962).

In Freytag , the Supreme Court exercised its discretion to decide an Appointments Clause challenge despite petitioners’ failure to raise a timely objection at trial. 501 U.S. at 878–79, 111 S.Ct. 2631. In fact, the Court reached the issue despite the fact that it had not been raised until the appellate stage. The Court explained that the structural and political roots of the separation of powers concept are embedded in the Appointments Clause. It concluded that the case was one of the "rare cases in which we should exercise our discretion to hear petitioners’ challenge to the constitutional authority." Id. at 879, 111 S.Ct. 2631. We believe that this case, like Freytag , is one of those exceptional cases that warrants consideration despite Arthrex’s failure to raise its Appointments Clause challenge before the Board. Like Freytag , this case implicates the important structural interests and separation of powers concerns protected by the Appointments Clause. Separation of powers is "a fundamental constitutional safeguard" and an "exceptionally important" consideration in the context of inter partes review proceedings. Cascades Projection LLC v. Epson America, Inc. , 864 F.3d 1309, 1322 (Fed. Cir. 2017) (Reyna, J., dissenting from denial of petition for hearing en banc). The issue presented today has a wide-ranging effect on property rights and the nation’s economy. Timely resolution is critical to providing certainty to rights holders and competitors alike who rely upon the inter partes review scheme to resolve concerns over patent rights.

Appellees and the government argue that like In re DBC we should decline to address the Appointments Clause challenge as waived. DBC recognized that the court retains discretion to reach issues raised for the first time on appeal, but declined to do so in that case. 545 F.3d 1373, 1380 (Fed. Cir. 2008). The court predicated its decision on the fact that if the issue had been raised before the Board, it could have corrected the Constitutional infirmity because there were Secretary appointed APJs and that Congress had taken "remedial action" redelegating the power of appointment to the Secretary of Commerce in an attempt to "eliminat[e] the issue of unconstitutional appointments going forward." Id. at 1380. As the court noted, "the Secretary, acting under the new statute, has reappointed the administrative patent judges involved in DBC’s appeal." Id. at 1381. Not only had Congress taken remedial action to address the constitutionality issue, the Secretary had already been implementing those remedies limiting the impact. Id. No such remedial action has been taken in this case and the Board could not have corrected the problem. Because the Secretary continues to have the power to appoint APJs and those APJs continue to decide patentability in inter partes review, we conclude that it is appropriate for this court to exercise its discretion to decide the Appointments Clause challenge here. This is an issue of exceptional importance, and we conclude it is an appropriate use of our discretion to decide the issue over a challenge of waiver.

B. Appointments Clause

Arthrex argues that the APJs who presided over this inter partes review were not constitutionally appointed. It argues the APJs were principal officers who must be, but were not, appointed by the President with the advice and consent of the Senate.

The Appointments Clause of Article II provides:

[The President] ... shall nominate, and by and with the Advice and Consent of the Senate, shall appoint Ambassadors, other public Ministers and Consuls, Judges of the supreme Court, and all other Officers of the United States, whose Appointments are not herein otherwise provided for, and which shall be established by Law: but the Congress may by Law vest the Appointment of such inferior Officers, as they think proper, in the President alone, in the Courts of Law, or in the Heads of Departments.

U.S. Const. art. II, § 2, cl. 2. APJs are appointed by the Secretary of Commerce, in consultation with the Director of the USPTO. 35 U.S.C. § 6(a). The issue, therefore, is whether APJs are "Officers of the United States" and if so, whether they are inferior officers or principal officers; the latter requiring appointment by the President as opposed to the Secretary of Commerce. We hold that in light of the rights and responsibilities in Title 35, APJs are principal officers.

An "Officer of the United States," as opposed to a mere employee, is someone who "exercis[es] significant authority pursuant to the laws of the United States." Buckley v. Valeo , 424 U.S. 1, 125–26, 96 S.Ct. 612, 46 L.Ed.2d 659 (1976). The Appointments Clause ensures that the individuals in these positions of significant authority are accountable to elected Executive officials. See Lucia , 138 S. Ct. at 2056 (Thomas, J., concurring) (citing The Federalist No. 76, p. 455 (C. Rossiter ed. 1961) (A....

To continue reading

Request your trial
209 cases
  • Helbert v. J K & G Coal Co., 20-0564 BLA
    • United States
    • Court of Appeals of Black Lung Complaints
    • February 28, 2022
    ...agency led by a single Director and vested with significant executive power."[9] 140 S.Ct. at 2201. It did not address ALJs. Finally, in Arthrex, the Supreme Court vacated the Circuit's judgment. 141 S.Ct. at 1988. The Court explained "the unreviewable authority wielded by APJs during inter......
  • Williams v. Patrick
    • United States
    • Court of Appeals of Black Lung Complaints
    • September 27, 2022
    ...2183 (2020), as well as the United States Court of Appeals for the Federal Circuit's holding in Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019), vacated, 594 U.S., 141 S.Ct. 1970 (2021). Id. Employer's arguments are without merit, as the only circuit court to squarely ......
  • Calcutt v. Fed. Deposit Ins. Corp.
    • United States
    • U.S. Court of Appeals — Sixth Circuit
    • June 10, 2022
    ..."sound discretion" whether to "allow additional briefing or reopen the record in any individual case." Arthrex, Inc. v. Smith & Nephew, Inc. , 941 F.3d 1320, 1340 (Fed. Cir. 2019), vacated on alternate grounds and remanded sub nom. United States v. Arthrex, Inc. , ––– U.S. ––––, 141 S. Ct. ......
  • Creech v. Apogee Coal Co.
    • United States
    • Court of Appeals of Black Lung Complaints
    • November 28, 2022
    ... ... by 30 U.S.C. §932(a); O'Keeffe v. Smith, ... Hinchman &Grylls Assocs., Inc. , 380 U.S. 359 ... for the Federal Circuit in Arthrex, Inc. v. Smith ... &Nephew, Inc. , 941 F.3d 1320 ... ...
  • Request a trial to view additional results
7 firm's commentaries
  • PTAB Digest 2021/2022: The Latest Trends and Developments in Post-Grant Proceedings
    • United States
    • JD Supra United States
    • July 25, 2022
    ...whereas Arthrex seeks to overturn the determination that severing removal restrictions would resolve the constitutional defect. 1 941 F.3d 1320 (Fed. Cir. 2019).2 See id. at 1329-34.3 Id. at 1335-38.DION M. BREGMANPartner | Silicon ValleyMICHAEL T. SIKORAAssociate | 24 ANNUAL PTAB DIGESTThe......
  • Sometimes Better Never Than Late
    • United States
    • Mondaq United States
    • December 15, 2022
    ...defend the Board's decisions. The Federal Circuit vacated and remanded the decisions in light of Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019) (Arthrex I). On remand, the Board administratively suspended the IPRs pending potential Supreme Court action, and while susp......
  • Spotlight On Upcoming Oral Arguments ' July 2020
    • United States
    • Mondaq United States
    • July 7, 2020
    ...an additional Administrative Procedure Act violation, citing the Federal Circuit's decision in Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019). The USPTO intervened, arguing that SecurityProfiling's waived the Arthrex issue by failing to raise the issue in or before it......
  • IPR Limbo During The Arthrex Decisions
    • United States
    • Mondaq United States
    • October 6, 2022
    ...round of appeals to the Federal Circuit, the Court vacated the decision and remanded in light of Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019), which raised Appointments Clause issues affecting IPRs generally. On remand, the IPRs were administratively suspended pendi......
  • Request a trial to view additional results
8 books & journal articles
  • The Strength of a Giant: The Administrative State and the United States Patent & Trademark Office
    • United States
    • The Georgetown Journal of Law & Public Policy No. 21-1, January 2023
    • January 1, 2023
    ...by Presidential nomination with advice and consent of the Senate.’”) (citation omitted). 119. Arthrex, Inc v. Smith & Nephew, Inc. 941 F.3d 1320, 1329 (Fed. Cir. 2019). 120. Id. at 1334. 121. See United States v. Gantt, 194 F.3d 987, 999 n.6; See also Note, Separation of Powers — Appointmen......
  • Private Delegation Outside of Executive Supervision.
    • United States
    • Harvard Journal of Law & Public Policy Vol. 45 No. 3, June 2022
    • June 22, 2022
    ...95 Notre Dame L. Rev. 87, 98 n.51 (2019); Lawson, America Invents, supra note 15. (117.) Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320, 1335 (Fed. Cir. (118.) See generally Arthrex, Inc. v. Smith & Nephew, Inc., 953 F.3d 760 (Fed. Cir. 2020) (denial of rehearing en banc). (11......
  • THE REDISCOVERED STAGES OF AGENCY ADJUDICATION.
    • United States
    • Washington University Law Review Vol. 99 No. 2, October 2021
    • October 1, 2021
    ...MASON L. REV. 643 (2021). The soundness of this structure may soon be tested in court. See Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019), cert, granted, 2020 WL 6037208 (Oct. 13, (38.) See 5 U.S.C. [section] 557(d)(1); Bremer, Reckoning, supra note 20, at 1778-80......
  • PATENT GROUPTHINK UNRAVELS.
    • United States
    • Harvard Journal of Law & Technology Vol. 34 No. 2, March 2021
    • March 22, 2021
    ...of patent cases") (quoting Weinberger v. Romero-Barcelo, 456 U.S. 305, 320 (1982)). (128.) Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320, 1327-28 (Fed. Cir. 2019), cert. granted, 141 S. Ct. 551 (2020). The case addresses the question as to whether administrative patent judges on ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT